Claire L Meaney1, Khadijah A Mitchell1, Adriana Zingone1, Derek Brown1, Elise Bowman1, Yunkai Yu2, Angela S Wenzlaff3, Christine Neslund-Dudas4, Sharon R Pine5, Liang Cao2, Ann G Schwartz3, Bríd M Ryan6. 1. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. 2. Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. 3. Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan. 4. Henry Ford Health System, Detroit, Michigan. 5. Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. 6. Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address: Brid.Ryan@nih.gov.
Abstract
INTRODUCTION: Lung cancer incidence is higher among African Americans (AAs) compared with European Americans (EAs) in the United States. We and others have previously shown a relationship between immune and inflammation proteins with lung cancer in EAs. Our aim was to investigate the etiologic relationship between inflammation and lung cancer in AAs. METHODS: We adopted a two-stage, independent study design (discovery cases, n = 316; control cases, n = 509) (validation cases, n = 399; control cases, n = 400 controls) and measured 30 inflammation proteins in blood using Meso Scale Discovery V- PLEX multiplex assays. RESULTS: We identified and validated 10 proteins associated with lung cancer in AAS, some that were common between EAs and AAs (C-reactive proteins [OR: 2.90; 95% confidence interval (CI): 1.99-4.22], interferon γ [OR: 1.55; 95% CI: 1.10-2.19], interleukin 6 [OR: 6.28; 95% CI: 4.10-9.63], interleukin 8 [OR: 2.76; 95% CI: 1.92-3.98]) and some that are only observed among AAs (interleukin 10 [OR: 1.69; 95% CI: 1.20-2.38], interleukin 15 [OR: 2.83; 95% CI: 1.96-4.07], interferon gamma-induced protein 10 [OR: 1.54; 95% CI: 1.09-2.18], monocyte chemotactic protein-4 [OR: 0.54; 95% CI: 0.38-0.76], macrophage inflammatory protein-1 alpha [OR: 1.57; 95% CI: 1.12-2.21], and tumor necrosis factor β [OR: 0.52; 95% CI: 0.37-0.74]). We did not find evidence that either menthol cigarette smoking or global genetic ancestry drove these population differences. CONCLUSIONS: Our results highlight a distinct inflammation profile associated with lung cancer in AAs compared with EAs. These data provide new insight into the etiology of lung cancer in AAs. Further work is needed to understand what drives this relationship with lung cancer and whether these proteins have utility in the setting of early diagnosis. Published by Elsevier Inc.
INTRODUCTION:Lung cancer incidence is higher among African Americans (AAs) compared with European Americans (EAs) in the United States. We and others have previously shown a relationship between immune and inflammation proteins with lung cancer in EAs. Our aim was to investigate the etiologic relationship between inflammation and lung cancer in AAs. METHODS: We adopted a two-stage, independent study design (discovery cases, n = 316; control cases, n = 509) (validation cases, n = 399; control cases, n = 400 controls) and measured 30 inflammation proteins in blood using Meso Scale Discovery V- PLEX multiplex assays. RESULTS: We identified and validated 10 proteins associated with lung cancer in AAS, some that were common between EAs and AAs (C-reactive proteins [OR: 2.90; 95% confidence interval (CI): 1.99-4.22], interferon γ [OR: 1.55; 95% CI: 1.10-2.19], interleukin 6 [OR: 6.28; 95% CI: 4.10-9.63], interleukin 8 [OR: 2.76; 95% CI: 1.92-3.98]) and some that are only observed among AAs (interleukin 10 [OR: 1.69; 95% CI: 1.20-2.38], interleukin 15 [OR: 2.83; 95% CI: 1.96-4.07], interferon gamma-induced protein 10 [OR: 1.54; 95% CI: 1.09-2.18], monocyte chemotactic protein-4 [OR: 0.54; 95% CI: 0.38-0.76], macrophage inflammatory protein-1 alpha [OR: 1.57; 95% CI: 1.12-2.21], and tumor necrosis factor β [OR: 0.52; 95% CI: 0.37-0.74]). We did not find evidence that either menthol cigarette smoking or global genetic ancestry drove these population differences. CONCLUSIONS: Our results highlight a distinct inflammation profile associated with lung cancer in AAs compared with EAs. These data provide new insight into the etiology of lung cancer in AAs. Further work is needed to understand what drives this relationship with lung cancer and whether these proteins have utility in the setting of early diagnosis. Published by Elsevier Inc.
Authors: Geoffrey M Curtin; Sandra I Sulsky; Cynthia Van Landingham; Kristin M Marano; Monica J Graves; Michael W Ogden; James E Swauger Journal: Regul Toxicol Pharmacol Date: 2014-07-02 Impact factor: 3.271
Authors: Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn Journal: Lancet Date: 2017-08-27 Impact factor: 79.321
Authors: Meredith S Shiels; Hormuzd A Katki; Allan Hildesheim; Ruth M Pfeiffer; Eric A Engels; Marcus Williams; Troy J Kemp; Neil E Caporaso; Ligia A Pinto; Anil K Chaturvedi Journal: J Natl Cancer Inst Date: 2015-07-28 Impact factor: 13.506
Authors: Ann G Schwartz; Michele L Cote; Angela S Wenzlaff; Alison Van Dyke; Wei Chen; John C Ruckdeschel; Shirish Gadgeel; Ayman O Soubani Journal: J Thorac Oncol Date: 2009-03 Impact factor: 15.609
Authors: Khadijah A Mitchell; Noah Nichols; Wei Tang; Jennifer Walling; Holly Stevenson; Marbin Pineda; Roxana Stefanescu; Daniel C Edelman; Andrew T Girvin; Adriana Zingone; Sanju Sinha; Elise Bowman; Emily L Rossi; Rony F Arauz; Yuelin Jack Zhu; Justin Lack; Elizabeth Weingartner; Joshua J Waterfall; Sharon R Pine; John Simmons; Paul Meltzer; Bríd M Ryan Journal: Nat Commun Date: 2019-12-16 Impact factor: 14.919
Authors: Rony F Arauz; Jung S Byun; Mayank Tandon; Sanju Sinha; Skyler Kuhn; Sheryse Taylor; Adriana Zingone; Khadijah A Mitchell; Sharon R Pine; Kevin Gardner; Eliseo J Perez-Stable; Anna M Napoles; Bríd M Ryan Journal: J Thorac Oncol Date: 2020-09-12 Impact factor: 15.609